{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:07:31Z","timestamp":1791986851553,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03497-2","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T01:01:40Z","timestamp":1693011700000},"page":"480-490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8899-684X","authenticated-orcid":false,"given":"Rosaria M.","family":"Ruggeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Benevento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"De Cicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Maria","family":"Grossrubatscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iderina","family":"Hasballa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Tarsitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Centello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia S.","family":"Pellegata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antongiulio","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"issue":"2","key":"3497_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","volume":"42","author":"ML Brandi","year":"2021","unstructured":"M.L. Brandi, S.K. Agarwal, N.D. Perrier, K.E. Lines, G.D. Valk, R.V. Thakker, Multiple Endocrine Neoplasia Type 1: latest insights. Endocr. Rev. 42(2), 133\u201370. (2021)","journal-title":"Endocr. Rev."},{"issue":"12","key":"3497_CR2","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"M.L. Brandi, R.F. Gagel, A. Angeli, J.P. Bilezikian, P. Beck-Peccoz, C. Bordi et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J. Clin. Endocrinol. Metab. 86(12), 5658\u20135671 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"3497_CR3","first-page":"3048","volume":"62","author":"A Fritz","year":"2002","unstructured":"A. Fritz, A. Walch, K. Piotrowska, M. Rosemann, E. Schaffer, K. Weber et al. Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Res. 62(11), 3048\u20133051 (2002)","journal-title":"Cancer Res."},{"issue":"42","key":"3497_CR4","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"NS Pellegata","year":"2006","unstructured":"N.S. Pellegata, L. Quintanilla-Martinez, H. Siggelkow, E. Samson, K. Bink, H. Hofler et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc. Natl. Acad. Sci. USA 103(42), 15558\u201315563 (2006)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"3497_CR5","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1210\/jc.2006-2843","volume":"92","author":"M Georgitsi","year":"2007","unstructured":"M. Georgitsi, A. Raitila, A. Karhu, R.B. van der Luijt, C.M. Aalfs, T. Sane et al. Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia. J. Clin. Endocrinol. Metab. 92(8), 3321\u20133325 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3497_CR6","first-page":"e220174","volume":"30","author":"R Halperin","year":"2022","unstructured":"R. Halperin, L. Arnon, S. Nasirov, L. Friedensohn, M. Gershinsky, A. Telerman, Germline CDKN1B variant type and site are associated with phenotype in MEN4. Endocr. Relat. Cancer 30(1), e220174 (2022)","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"3497_CR7","doi-asserted-by":"publisher","first-page":"e220411","DOI":"10.1530\/EC-22-0411","volume":"12","author":"H Singeisen","year":"2023","unstructured":"H. Singeisen, M.M. Renzulli, V. Pavlicek, P. Probst, F. Hauswirth, M.K. Muller, Multiple endocrine neoplasia type 4: a new member of the MEN family. Endocr. Connect. 12(2), e220411 (2023)","journal-title":"Endocr. Connect"},{"issue":"17","key":"3497_CR8","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1158\/0008-5472.CAN-19-3663","volume":"80","author":"SF Razavipour","year":"2020","unstructured":"S.F. Razavipour, K.B. Harikumar, J.M. Slingerland, p27 as a transcriptional regulator: new roles in development and cancer. Cancer Res. 80(17), 3451\u20133458 (2020)","journal-title":"Cancer Res."},{"key":"3497_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.canlet.2017.06.031","volume":"403","author":"D Bencivenga","year":"2017","unstructured":"D. Bencivenga, I. Caldarelli, E. Stampone, F.P. Mancini, M.L. Balestrieri, F. Della Ragione et al. p27(Kip1) and human cancers: a reappraisal of a still enigmatic protein. Cancer Lett. 403, 354\u201365. (2017)","journal-title":"Cancer Lett."},{"key":"3497_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.stem.2012.09.014","volume":"11","author":"H Li","year":"2012","unstructured":"H. Li, M. Collado, A. Villasante, A. Matheu, C.J. Lynch, M. Canamero et al. p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation. Cell Stem Cell 11, 845\u2013852 (2012)","journal-title":"Cell Stem Cell"},{"key":"3497_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2004.11.025","volume":"7","author":"G Baldassarre","year":"2005","unstructured":"G. Baldassarre, B. Belletti, M.S. Nicoloso, M. Schiappacassi, A. Vecchione, P. Spessotto et al. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7, 51\u201363 (2005)","journal-title":"Cancer Cell"},{"key":"3497_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jcb.20187","volume":"93","author":"CI Rubin","year":"2004","unstructured":"C.I. Rubin, G.F. Atweh, The role of stathmin in the regulation of the cell cycle. J. Cell Biochem. 93, 242\u2013250 (2004)","journal-title":"J. Cell Biochem."},{"key":"3497_CR13","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.bbamcr.2018.08.010","volume":"1865","author":"RT Perchey","year":"2018","unstructured":"R.T. Perchey, M.P. Serres, A. Nowosad, J. Creff, C. Callot, A. Gay et al. p27(Kip1) regulates the microtubule bundling activity of PRC1. Biochim. Biophys. Acta Mol. Cell Res. 1865, 1630\u20131639 (2018)","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"5","key":"3497_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1042\/BST20160172","volume":"44","author":"MM Babu","year":"2016","unstructured":"M.M. Babu, The contribution of intrinsically disordered regions to protein function, cellular complexity, and human disease. Biochem. Soc. Trans. 44(5), 1185\u2013200. (2016)","journal-title":"Biochem. Soc. Trans."},{"issue":"12","key":"3497_CR15","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1080\/15548627.2020.1831217","volume":"16","author":"A Nowosad","year":"2020","unstructured":"A. Nowosad, A. Besson, CDKN1B\/p27 regulates autophagy via the control of Ragulator and MTOR activity in amino acid-deprived cells. Autophagy 16(12), 2297\u20132298 (2020)","journal-title":"Autophagy"},{"issue":"2","key":"3497_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.15403\/jgld.2014.1121.242.skp2","volume":"24","author":"OV Bochis","year":"2015","unstructured":"O.V. Bochis, A. Irimie, M. Pichler, I. Berindan-Neagoe, The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer. J. Gastrointestin Liver Dis. 24(2), 225\u2013234 (2015)","journal-title":"J. Gastrointestin Liver Dis."},{"issue":"8","key":"3497_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1182\/blood-2015-04-643361","volume":"126","author":"S Dietrich","year":"2015","unstructured":"S. Dietrich, J. Hullein, S.C. Lee, B. Hutter, D. Gonzalez, S. Jayne et al. Recurrent CDKN1B (p27) mutations in hairy cell leukemia. Blood 126(8), 1005\u20131008 (2015)","journal-title":"Blood"},{"issue":"2","key":"3497_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/path.5584","volume":"253","author":"D Viotto","year":"2021","unstructured":"D. Viotto, F. Russo, I. Anania, I. Segatto, G.L. Rampioni Vinciguerra, A. Dall\u2019Acqua et al. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer. J. Pathol. 253(2), 234\u201345. (2021)","journal-title":"J. Pathol."},{"issue":"6","key":"3497_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","volume":"44","author":"CE Barbieri","year":"2012","unstructured":"C.E. Barbieri, S.C. Baca, M.S. Lawrence, F. Demichelis, M. Blattner, J.P. Theurillat et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44(6), 685\u2013689 (2012)","journal-title":"Nat. Genet."},{"issue":"12","key":"3497_CR20","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ng.2821","volume":"45","author":"JM Francis","year":"2013","unstructured":"J.M. Francis, A. Kiezun, A.H. Ramos, S. Serra, C.S. Pedamallu, Z.R. Qian et al. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat. Genet. 45(12), 1483\u20131486 (2013)","journal-title":"Nat. Genet."},{"issue":"12","key":"3497_CR21","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1055\/s-0042-118613","volume":"48","author":"CS Martins","year":"2016","unstructured":"C.S. Martins, R.C. Camargo, F.P. Saggioro, L. Neder, H.R. Machado, A.C. Moreira et al. P27\/CDKN1B translational regulators in pituitary tumorigenesis. Horm. Metab. Res. 48(12), 840\u2013846 (2016)","journal-title":"Horm. Metab. Res."},{"issue":"8","key":"3497_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.18632\/aging.100786","volume":"7","author":"B Belletti","year":"2015","unstructured":"B. Belletti, G. Baldassarre, Roles of CDKN1B in cancer? Aging (Albany NY) 7(8), 529\u2013530 (2015)","journal-title":"Aging (Albany NY)"},{"issue":"1-2","key":"3497_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"R.V. Thakker, Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol. Cell Endocrinol. 386(1-2), 2\u201315 (2014)","journal-title":"Mol. Cell Endocrinol."},{"issue":"41","key":"3497_CR24","doi-asserted-by":"publisher","first-page":"14659","DOI":"10.1073\/pnas.0503484102","volume":"102","author":"SK Karnik","year":"2005","unstructured":"S.K. Karnik, C.M. Hughes, X. Gu, O. Rozenblatt-Rosen, G.W. McLean, Y. Xiong et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl. Acad. Sci. USA 102(41), 14659\u201314664 (2005)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7386","key":"3497_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature10806","volume":"482","author":"J Huang","year":"2012","unstructured":"J. Huang, B. Gurung, B. Wan, S. Matkar, N.A. Veniaminova, K. Wan et al. The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature 482(7386), 542\u2013546 (2012)","journal-title":"Nature"},{"issue":"2","key":"3497_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12020-016-0941-6","volume":"55","author":"S Borsari","year":"2017","unstructured":"S. Borsari, E. Pardi, N.S. Pellegata, M. Lee, F. Saponaro, L. Torregrossa et al. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas. Endocrine 55(2), 386\u201397. (2017)","journal-title":"Endocrine"},{"issue":"10","key":"3497_CR27","doi-asserted-by":"publisher","first-page":"T195","DOI":"10.1530\/ERC-17-0243","volume":"24","author":"R Alrezk","year":"2017","unstructured":"R. Alrezk, F. Hannah-Shmouni, C.A. Stratakis, MEN4 and CDKN1B mutations: the latest of the MEN syndromes. Endocr. Relat. Cancer 24(10), T195\u2013T208 (2017)","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"3497_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1073\/pnas.0408836102","volume":"102","author":"TA Milne","year":"2005","unstructured":"T.A. Milne, C.M. Hughes, R. Lloyd, Z. Yang, O. Rozenblatt-Rosen, Y. Dou et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. USA 102(3), 749\u2013754 (2005)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"3497_CR29","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1210\/jc.2008-2083","volume":"94","author":"SK Agarwal","year":"2009","unstructured":"S.K. Agarwal, C.M. Mateo, S.J. Marx, Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J. Clin. Endocrinol. Metab. 94(5), 1826\u20131834 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"3497_CR30","doi-asserted-by":"publisher","first-page":"E1825","DOI":"10.1002\/humu.21354","volume":"31","author":"S Molatore","year":"2010","unstructured":"S. Molatore, I. Marinoni, M. Lee, E. Pulz, M.R. Ambrosio, E.C. degli Uberti et al. A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Hum. Mutat. 31(11), E1825\u2013E1835 (2010)","journal-title":"Hum. Mutat."},{"issue":"1","key":"3497_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"M.C. Lemos, R.V. Thakker, Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum. Mutat. 29(1), 22\u201332 (2008)","journal-title":"Hum. Mutat."},{"issue":"1-2","key":"3497_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","volume":"209","author":"P Concolino","year":"2016","unstructured":"P. Concolino, A. Costella, E. Capoluongo, Multiple endocrine neoplasia type 1 (MEN1): an update of 208 new germline variants reported in the last nine years. Cancer Genet. 209(1-2), 36\u201341 (2016)","journal-title":"Cancer Genet."},{"issue":"6","key":"3497_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr.","year":"2015","unstructured":"S.A. Wells Jr., S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25(6), 567\u2013610 (2015)","journal-title":"Thyroid"},{"issue":"1","key":"3497_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.surg.2017.04.044","volume":"163","author":"I Christakis","year":"2018","unstructured":"I. Christakis, W. Qiu, S.M. Hyde, G.J. Cote, E.G. Grubbs, N.D. Perrier et al. Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: a 23-year experience at a single institution. Surgery 163(1), 212\u2013217 (2018)","journal-title":"Surgery"},{"key":"3497_CR35","doi-asserted-by":"publisher","first-page":"543246","DOI":"10.3389\/fendo.2020.543246","volume":"11","author":"SY Li","year":"2020","unstructured":"S.Y. Li, Y.Q. Ding, Y.L. Si, M.J. Ye, C.M. Xu, X.P. Qi, 5P strategies for management of multiple endocrine neoplasia Type 2: a paradigm of precision medicine. Front. Endocrinol. (Lausanne) 11, 543246 (2020)","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10","key":"3497_CR36","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/emboj\/19.10.2168","volume":"19","author":"D Muller","year":"2000","unstructured":"D. Muller, K. Thieke, A. Burgin, A. Dickmanns, M. Eilers, Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60. EMBO J. 19(10), 2168\u20132180 (2000)","journal-title":"EMBO J."},{"issue":"4","key":"3497_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","volume":"76","author":"A Sakurai","year":"2012","unstructured":"A. Sakurai, S. Suzuki, S. Kosugi, T. Okamoto, S. Uchino, A. Miya et al. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin. Endocrinol. (Oxf.) 76(4), 533\u2013539 (2012)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"9","key":"3497_CR38","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-0476","volume":"92","author":"E Tham","year":"2007","unstructured":"E. Tham, U. Grandell, E. Lindgren, G. Toss, B. Skogseid, M. Nordenskjold, Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J. Clin. Endocrinol. Metab. 92(9), 3389\u20133395 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3497_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1530\/EJE-18-0430","volume":"179","author":"RA Carvalho","year":"2018","unstructured":"R.A. Carvalho, B. Urtremari, A.A.L. Jorge, L.S. Santana, E.P.S. Quedas, T. Sekiya et al. Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing. Eur. J. Endocrinol. 179(6), 391\u2013407 (2018)","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"3497_CR40","doi-asserted-by":"publisher","first-page":"T119","DOI":"10.1530\/ERC-17-0199","volume":"24","author":"SK Agarwal","year":"2017","unstructured":"S.K. Agarwal, The future: genetics advances in MEN1 therapeutic approaches and management strategies. Endocr. Relat. Cancer 24(10), T119\u2013T34. (2017)","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"3497_CR41","doi-asserted-by":"publisher","first-page":"E1089","DOI":"10.1002\/humu.21170","volume":"31","author":"JJ Turner","year":"2010","unstructured":"J.J. Turner, P.T. Christie, S.H. Pearce, P.D. Turnpenny, R.V. Thakker, Diagnostic challenges due to phenocopies: lessons from multiple Endocrine Neoplasia type1 (MEN1). Hum. Mutat. 31(1), E1089\u2013E1101 (2010)","journal-title":"Hum. Mutat."},{"issue":"6","key":"3497_CR42","doi-asserted-by":"publisher","first-page":"e2271","DOI":"10.1210\/clinem\/dgaa142","volume":"105","author":"LB Nachtigall","year":"2020","unstructured":"L.B. Nachtigall, F.J. Guarda, K.E. Lines, A. Ghajar, L. Dichtel, G. Mumbach et al. Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly. J. Clin. Endocrinol. Metab. 105(6), e2271\u2013e2281 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3497_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1365-2265.2000.01032.x","volume":"53","author":"JR Burgess","year":"2000","unstructured":"J.R. Burgess, B. Nord, R. David, T.M. Greenaway, V. Parameswaran, C. Larsson et al. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1). Clin. Endocrinol. (Oxf.) 53(2), 205\u2013211 (2000)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"Suppl 3","key":"3497_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4158\/EP10379.RA","volume":"17","author":"PJ Newey","year":"2011","unstructured":"P.J. Newey, R.V. Thakker, Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice. Endocr. Pract. 17(Suppl 3), 8\u201317 (2011)","journal-title":"Endocr. Pract."},{"issue":"4","key":"3497_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/ajco.12046","volume":"9","author":"RW Carroll","year":"2013","unstructured":"R.W. Carroll, Multiple endocrine neoplasia type 1 (MEN1). Asia Pac. J. Clin. Oncol. 9(4), 297\u2013309 (2013)","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"2","key":"3497_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.14341\/probl12413","volume":"66","author":"EO Mamedova","year":"2020","unstructured":"E.O. Mamedova, D.A. Dimitrova, Z.E. Belaya, G.A. Melnichenko,, The role of non-coding RNAs in the pathogenesis of multiple endocrine neoplasia syndrome type 1. Probl. Endokrinol. 66(2), 4\u201312 (2020).","journal-title":"Probl. Endokrinol."},{"issue":"4","key":"3497_CR47","first-page":"1743","volume":"9","author":"E Luzi","year":"2017","unstructured":"E. Luzi, S. Ciuffi, F. Marini, C. Mavilia, G. Galli, M.L. Brandi, Analysis of differentially expressed microRNAs in MEN1 parathyroid adenomas. Am. J. Transl. Res. 9(4), 1743\u201353. (2017)","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"3497_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","volume":"32","author":"LR Yates","year":"2017","unstructured":"L.R. Yates, S. Knappskog, D. Wedge, J.H.R. Farmery, S. Gonzalez, I. Martincorena et al. Genomic evolution of breast cancer metastasis and relapse. Cancer Cell 32(2), 169\u2013184 e7 (2017)","journal-title":"Cancer Cell"},{"issue":"4","key":"3497_CR49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.eururo.2013.05.029","volume":"64","author":"CE Barbieri","year":"2013","unstructured":"C.E. Barbieri, C.H. Bangma, A. Bjartell, J.W. Catto, Z. Culig, H. Gronberg et al. The mutational landscape of prostate cancer. Eur. Urol. 64(4), 567\u2013576 (2013)","journal-title":"Eur. Urol."},{"key":"3497_CR50","doi-asserted-by":"publisher","first-page":"773143","DOI":"10.3389\/fendo.2022.773143","volume":"13","author":"E Lavezzi","year":"2022","unstructured":"E. Lavezzi, A. Brunetti, V. Smiroldo, G. Nappo, V. Pedicini, E. Vitali et al. Case report: new CDKN1B mutation in multiple Endocrine Neoplasia Type 4 and brief literature review on clinical management. Front. Endocrinol. 13, 773143 (2022)","journal-title":"Front. Endocrinol."},{"issue":"7","key":"3497_CR51","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00268-001-0046-z","volume":"25","author":"P Goudet","year":"2001","unstructured":"P. Goudet, P. Cougard, B. Verges, A. Murat, B. Carnaille, A. Calender et al. Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D\u2019etude des Neoplasies Endocriniennes Multiples Study Group. World J. Surg. 25(7), 886\u2013890 (2001)","journal-title":"World J. Surg."},{"key":"3497_CR52","first-page":"510985","volume":"2015","author":"MS Elston","year":"2015","unstructured":"M.S. Elston, G.Y. Meyer-Rochow, M. Dray, M. Swarbrick, J.V. Conaglen, Early onset primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B. Case Rep. Endocrinol. 2015, 510985 (2015)","journal-title":"Case Rep. Endocrinol."},{"issue":"4","key":"3497_CR53","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2014-3659","volume":"100","author":"P Goudet","year":"2015","unstructured":"P. Goudet, A. Dalac, M. Le Bras, C. Cardot-Bauters, P. Niccoli, N. Levy-Bohbot et al. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2019etude des Tumeurs Endocrines. J. Clin. Endocrinol. Metab. 100(4), 1568\u20131577 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3497_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","volume":"87","author":"B Verges","year":"2002","unstructured":"B. Verges, F. Boureille, P. Goudet, A. Murat, A. Beckers, G. Sassolas et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J. Clin. Endocrinol. Metab. 87(2), 457\u2013465 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"3497_CR55","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1210\/JC.2015-2015","volume":"100","author":"JM de Laat","year":"2015","unstructured":"J.M. de Laat, O.M. Dekkers, C.R. Pieterman, W.P. Kluijfhout, A.R. Hermus, A.M. Pereira et al. Long-term natural course of pituitary tumors in patients with MEN1: results From the DutchMEN1 Study Group (DMSG). J. Clin. Endocrinol. Metab. 100(9), 3288\u20133296 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3497_CR56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/ERC-11-0362","volume":"19","author":"MA Tichomirowa","year":"2012","unstructured":"M.A. Tichomirowa, M. Lee, A. Barlier, A.F. Daly, I. Marinoni, M.L. Jaffrain-Rea et al. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds. Endocr. Relat. Cancer 19(3), 233\u2013241 (2012)","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"3497_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/cen.13264","volume":"86","author":"D Donegan","year":"2017","unstructured":"D. Donegan, N. Singh Ospina, R. Rodriguez-Gutierrez, Z. Al-Hilli, G.B. Thompson, B.L. Clarke et al. Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours. Clin. Endocrinol. 86(2), 199\u2013206 (2017)","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"3497_CR58","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2019-00082","volume":"104","author":"A Frederiksen","year":"2019","unstructured":"A. Frederiksen, M. Rossing, P. Hermann, C. Ejersted, R.V. Thakker, M. Frost, Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel pathogenic variant and review of published cases. J. Clin. Endocrinol. Metab. 104(9), 3637\u201346. (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"3497_CR59","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97(9), 2990\u20133011 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3497_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67424-5","volume":"10","author":"HR Choi","year":"2020","unstructured":"H.R. Choi, S.H. Choi, S.M. Choi, J.K. Kim, C.R. Lee, S.W. Kang et al. Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism. Sci. Rep. 10(1), 10634 (2020)","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"3497_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.6061\/clinics\/2012(Sup01)23","volume":"67","author":"F Giusti","year":"2012","unstructured":"F. Giusti, F. Tonelli, M.L. Brandi, Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery. Clinics 67(Suppl 1), 141\u2013144 (2012). Suppl 1","journal-title":"Clinics"},{"issue":"3","key":"3497_CR62","first-page":"201","volume":"53","author":"N Aygun","year":"2019","unstructured":"N. Aygun, M. Uludag, Surgical treatment of primary hyperparathyroidism: which therapy to whom? Sisli Etfal Hastan. Tip. Bul. 53(3), 201\u201314. (2019)","journal-title":"Sisli Etfal Hastan. Tip. Bul."},{"issue":"5","key":"3497_CR63","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"M.E. Molitch, Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5), 516\u2013524 (2017)","journal-title":"JAMA"},{"issue":"1","key":"3497_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-015-0540-y","volume":"49","author":"S Sambugaro","year":"2015","unstructured":"S. Sambugaro, M. Di Ruvo, M.R. Ambrosio, N.S. Pellegata, M. Bellio, A. Guerra et al. Early onset acromegaly associated with a novel deletion in CDKN1B 5\u2019UTR region. Endocrine 49(1), 58\u201364 (2015)","journal-title":"Endocrine"},{"issue":"4","key":"3497_CR65","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40618-021-01705-2","volume":"45","author":"V Andreasi","year":"2022","unstructured":"V. Andreasi, C. Ricci, S. Partelli, G. Guarneri, C. Ingaldi, F. Muffatti et al. Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis. J. Endocrinol. Investig. 45(4), 705\u201318. (2022)","journal-title":"J. Endocrinol. Investig."},{"issue":"4","key":"3497_CR66","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/OP.21.00240","volume":"18","author":"JY Zhang","year":"2022","unstructured":"J.Y. Zhang, P.L. Kunz, Making sense of a complex disease: a practical approach to managing Neuroendocrine Tumors. JCO Oncol. Pract. 18(4), 258\u201364. (2022)","journal-title":"JCO Oncol. Pract."},{"issue":"4","key":"3497_CR67","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc2347","volume":"8","author":"IM Chu","year":"2008","unstructured":"I.M. Chu, L. Hengst, J.M. Slingerland, The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8(4), 253\u2013267 (2008)","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"3497_CR68","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1074\/jbc.275.10.6987","volume":"275","author":"D Busse","year":"2000","unstructured":"D. Busse, R.S. Doughty, T.T. Ramsey, W.E. Russell, J.O. Price, W.M. Flanagan et al. Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity. J. Biol. Chem. 275(10), 6987\u20136995 (2000)","journal-title":"J. Biol. Chem."},{"issue":"4","key":"3497_CR69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4161\/cc.2.4.433","volume":"2","author":"J Liang","year":"2003","unstructured":"J. Liang, J.M. Slingerland, Multiple roles of the PI3K\/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2(4), 339\u2013345 (2003)","journal-title":"Cell Cycle"},{"issue":"3","key":"3497_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/cancers10030078","volume":"10","author":"K Szymonowicz","year":"2018","unstructured":"K. Szymonowicz, S. Oeck, N.M. Malewicz, V. Jendrossek, New Insights into Protein Kinase B\/Akt Signaling: role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response. Cancers (Basel) 10(3), 78 (2018)","journal-title":"Cancers (Basel)"},{"issue":"16","key":"3497_CR71","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/onc.2012.226","volume":"32","author":"K Shanmugasundaram","year":"2013","unstructured":"K. Shanmugasundaram, K. Block, B.K. Nayak, C.B. Livi, M.A. Venkatachalam, S. Sudarshan, PI3K regulation of the SKP-2\/p27 axis through mTORC2. Oncogene 32(16), 2027\u20132036 (2013)","journal-title":"Oncogene"},{"issue":"3","key":"3497_CR72","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2741\/4320","volume":"20","author":"Z Hao","year":"2015","unstructured":"Z. Hao, S. Huang, E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy. Front. Biosci. (Landmark Ed.) 20(3), 474\u2013490 (2015)","journal-title":"Front. Biosci. (Landmark Ed.)"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03497-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03497-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03497-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T02:21:00Z","timestamp":1698718860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03497-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":72,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3497"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03497-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}